Meridian Bioscience (VIVO) Tops Q4 EPS by 4c, Revenue Beat; Offers FY19 EPS Guidance Below Consensus
Go back to Meridian Bioscience (VIVO) Tops Q4 EPS by 4c, Revenue Beat; Offers FY19 EPS Guidance Below Consensus| Meridian Bioscience, Inc. (NASDAQ: VIVO) | Delayed: 3.83 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.83 | 52 Week High | $21.49 | |||
| Open | $3.83 | 52 Week Low | $15.75 | |||
| Day High | $3.83 | P/E | 4.35 | |||
| Day Low | $3.83 | EPS | $0.88 | |||
| Volume | 128 | |||||
